UnitedHealth shares fell more than 7.6% to hit a two-month low, lowering the full-year adjusted earnings guidance.

UnitedHealth Group's stock fell more than 7.6% in early trading, hitting a low of $260.55, a new low in over two months. In terms of news, UnitedHealth Group's Q2 revenue was $111.6 billion, slightly higher than the market's expected $111.59 billion; adjusted earnings per share were $4.08, lower than the market's expected $4.22. Due to higher than expected medical costs in various business lines, the medical loss ratio rose to 89.4%, higher than the market's expected 89.3%. The company updated its 2025 performance outlook, expecting revenue to be between $445.5 billion and $448 billion, with adjusted earnings per share of $16, far lower than the previous expectation of $26 to $26.5.